Biotronik has announced the positive six-month results from the DELUX registry and 12-month results from the PEPPER study of its Pantera Lux paclitaxel-releasing balloon.

The Pantera Lux paclitaxel-releasing balloon, based on the Pantera semi-compliant balloon, is used to treat restenotic coronary artery lesions after drug-eluting or bare-metal stenting.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The prospective, multicentre, non-randomised and international DELUX study involved 1,000 patients and showed good safety and efficacy with low revascularisation and myocardial infarction rates.

The 81-patient prospective multicentre non-randomised European first-in-man PEPPER study demonstrated the primary endpoint of in-stent late lumen loss of 0.07mm with effective inhibition of neointimal proliferation in all patients.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact